Find Velpatasvir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

117 RELATED EXCIPIENT COMPANIES

193EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1377049-84-7, Gs-5816, Gs5816, Kcu0c7rs7z, Gs 5816, Methyl ((r)-2-((2s,4s)-2-(5-(2-((2s,5s)-1-((methoxycarbonyl)-l-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate
Molecular Formula
C49H54N8O8
Molecular Weight
883.0  g/mol
InChI Key
FHCUMDQMBHQXKK-CDIODLITSA-N
FDA UNII
KCU0C7RS7Z

Velpatasvir
Velpatasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV genotypes 1-6. Although the exact mechanism of action of velpatasvir has not yet been completely determined, upon oral administration and intracellular uptake, it appears to bind to domain I of the NS5A protein. This inhibits the activity of the NS5A protein and results in the disruption of the viral RNA replication complex, blockage of viral HCV RNA production, and inhibition of viral replication. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.
Velpatasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of velpatasvir is as a Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Organic Anion Transporting Polypeptide 2B1 Inhibitor.
1 2D Structure

Velpatasvir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl N-[(1R)-2-[(2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
2.1.2 InChI
InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1
2.1.3 InChI Key
FHCUMDQMBHQXKK-CDIODLITSA-N
2.1.4 Canonical SMILES
CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC
2.1.5 Isomeric SMILES
C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC
2.2 Other Identifiers
2.2.1 UNII
KCU0C7RS7Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gs-5816

2.3.2 Depositor-Supplied Synonyms

1. 1377049-84-7

2. Gs-5816

3. Gs5816

4. Kcu0c7rs7z

5. Gs 5816

6. Methyl ((r)-2-((2s,4s)-2-(5-(2-((2s,5s)-1-((methoxycarbonyl)-l-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate

7. Methyl [(2s)-1-[(2s,5s)-2-[9-[2-[(2s,4s)-1-[(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

8. Methyl N-[(1r)-2-[(2s,4s)-2-[5-[6-[(2s,5s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

9. Unii-kcu0c7rs7z

10. Velpatasvir [usan:inn]

11. Verpatasvir

12. Methyl ((2s)-1-((2s,5s)-2-(9-(2-((2s,4s)-1-((2r)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

13. Methyl {(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

14. Velpatasvir [inn]

15. Velpatasvir(gs5816)

16. Velpatasvir [mi]

17. Velpatasvir [jan]

18. Velpatasvir; Gs-5816

19. Velpatasvir [usan]

20. Velpatasvir [who-dd]

21. Velpatasvir (jan/usan/inn)

22. Schembl8756902

23. Chembl3545062

24. Schembl19236068

25. Gtpl11269

26. Amy4211

27. Dtxsid70722565

28. Velpatasvir [orange Book]

29. Chebi:133009

30. Epclusa (sofosbuvir + Velpatasvir)

31. Vosevi Component Velpatasvir

32. Bcp13813

33. Epclusa Component Velpatasvir

34. Ex-a2320

35. Bdbm50521720

36. Mfcd28411371

37. S3724

38. Velpatasvir Component Of Vosevi

39. Zinc203686879

40. Ccg-270553

41. Cs-5977

42. Db11613

43. Velpatasvir Component Of Epclusa

44. Ncgc00522503-01

45. Ncgc00522503-02

46. Ac-28744

47. As-35237

48. Hy-12530

49. Ft-0700879

50. J3.631.686a

51. D10806

52. Gs-5816;gs5816;gs 5816

53. Vosevi (sofosbuvir + Velpatasvir + Voxilaprevi)

54. A886410

55. Q25018296

56. Carbamic Acid, N-[(1r)-2-[(2s,4s)-2-[5-[1,11-dihydro-2-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4,3:6,7]naphth[1,2-d]imidazol-9-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, Methyl Ester

57. Methyl {(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

58. Methyl N-[(1r)-2-[(2s,4s)-2-(5-{6-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1,3,6,8,10,12,14,16,18-nonaen-17-yl}-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

59. Methyl N-[(1r)-2-[(2s,4s)-2-(5-{6-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.0?,?.01?,1?]henicosa-1,3,6,8,10,12,14,16,18-nonaen-17-yl}-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

60. Methyl{(2s)-1-[(2s,5s)-2-(9-{2-[(2s,4s)-1-{(2r)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1h-imidazol-5-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

2.4 Create Date
2012-11-30
3 Chemical and Physical Properties
Molecular Weight 883.0 g/mol
Molecular Formula C49H54N8O8
XLogP36.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count10
Rotatable Bond Count13
Exact Mass882.40646071 g/mol
Monoisotopic Mass882.40646071 g/mol
Topological Polar Surface Area193 Ų
Heavy Atom Count65
Formal Charge0
Complexity1690
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameEPCLUSA
Active IngredientSOFOSBUVIR; VELPATASVIR
CompanyGILEAD SCIENCES INC (Application Number: N208341. Patents: 7964580, 8334270, 8575135, 8580765, 8618076, 8633309, 8735372, 8889159, 8921341, 8940718, 9085573, 9284342, 9757406)

2 of 2  
Drug NameVOSEVI
Active IngredientSOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
CompanyGILEAD SCIENCES INC (Application Number: N209195. Patents: 7964580, 8334270, 8575135, 8580765, 8618076, 8633309, 8735372, 8889159, 8921341, 8940718, 9085573, 9284342, 9296782, 9585906)

4.2 Drug Indication

Velpatasvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients. Depending on the level of cirrhosis or decompensation, combination therapy can also include therapy with [DB00811]. When used in combination with [DB08934] as the combination product Epclusa, Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, or in combination with [DB00811] if associated with decompensated cirrhosis.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Velpatasvir is a small molecule direct-acting antiviral used in the treatment of hepatitis C in combination with sofosbuvir. Velpatasvir prevents viral replication by inhibiting non-structural protein 5A (NS5A). At a dose 5 times the recommended dose, velpatasvir does not prolong QTc interval to any clinically relevant extent.


5.2 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
VELPATASVIR
5.3.2 FDA UNII
KCU0C7RS7Z
5.3.3 Pharmacological Classes
Mechanisms of Action [MoA] - Organic Anion Transporting Polypeptide 2B1 Inhibitors
5.4 Absorption, Distribution and Excretion

Absorption

Oral bioavailability of 25-30%.


Route of Elimination

94% excreted in feces with 77% as parent compound. 0.4% excreted in urine.


Volume of Distribution

1.4-1.6 L/kg.


Clearance

Estimated 0.12 L/h/kg [A19175.


5.5 Metabolism/Metabolites

Some metabolism by CYP2B6, CYP2C8, and CYP3A4.


5.6 Biological Half-Life

15h.


5.7 Mechanism of Action

Velpatasvir's mechanism of action is likely similar to other selective NS5A inhibitors which bind domain I of NS5A consisting of amino acids 33-202. NS5A inhibitors compete with RNA for binding at this site. It is also thought that NS5A inhibitors bind the target during its action in replication when the binding site is exposed. Inhibition of NS5A is also known to produce redistribution of the protein to lipid droplets. The exact role of NS5A in RNA replication is not yet understood although it is known to be an important component.


API SUPPLIERS

read-more
read-more

01

Century Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentury has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Century Company Banner

02

Aspen Biopharma Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

03

Changzhou Pharmaceutical Factory

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

04

Bulat Pharmaceutical

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

05

Beijing Mesochem Technology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

06

Aspire Lifesciences Pvt Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

07

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

08

Mangalam Drugs & Organics Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

09

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

10

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624645800,"product":"VELPATASVIR COPOVIDONE","address":"4-7-101 SCIENTIST COLONY,HABSIGUDA","city":"HYDERABAD, TELANGANA","supplier":"OPTRIX LABORATORIES PRIVATE ","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"ALBARAKA BANK PAKISTAN ","customerCountry":"PAKISTAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2455.5","totalValueFC":"7216.6","currency":"USD","unitRateINR":176915.83333333334,"date":"26-Jun-2021","totalValueINR":"530747.5","totalValueInUsd":"7216.6","indian_port":"HYDERABAD AIR","hs_no":"29141990","bill_no":"2693546","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"4-7-101 SCIENTIST COLONY,HABSIGUDA, HYDERABAD, TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647282600,"product":"VELPATASVIR COPOVIDONE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"BAGHDAD","customer":"SAMA ALFAYHAA PHARMACEUTICAL ","customerCountry":"IRAQ","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"4395.5","totalValueFC":"8644.6","currency":"USD","unitRateINR":329442.5,"date":"15-Mar-2022","totalValueINR":"658885","totalValueInUsd":"8644.6","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29349990","bill_no":"4000827","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"IRAQ","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665945000,"product":"VELPATASVIR PREMIX (VELPATASVIR PREMIX)","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"ZYDUS LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"YANGON","customer":"ALIDAC HEALTHCARE ( MYANMAR) LIMITE","customerCountry":"MYANMAR","quantity":"10.83","actualQuantity":"10.825","unit":"KGS","unitRateFc":"7289.8","totalValueFC":"77256.6","currency":"USD","unitRateINR":587251.73210161668,"date":"17-Oct-2022","totalValueINR":"6357000","totalValueInUsd":"77256.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4877695","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MYANMAR","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668537000,"product":"VELPATASVIR SOLID DISPERSION 50% W\/W","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LIMITED","customerCountry":"PAKISTAN","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"4600","totalValueFC":"231140.6","currency":"USD","unitRateINR":377280,"date":"16-Nov-2022","totalValueINR":"18864000","totalValueInUsd":"231140.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5494647","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699813800,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LIMITED","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"4550","totalValueFC":"112428.3","currency":"USD","unitRateINR":374480,"date":"13-Nov-2023","totalValueINR":"9362000","totalValueInUsd":"112428.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5332746","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700591400,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"HABIB BANK LIMITED","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"4550","totalValueFC":"112368.2","currency":"USD","unitRateINR":374280,"date":"22-Nov-2023","totalValueINR":"9357000","totalValueInUsd":"112368.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5484219","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714329000,"product":"VELPATASVIR SOLID DISPERSION 50%W\/W","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MEEZAN BANK LIMITED","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"3000","totalValueFC":"74103.3","currency":"USD","unitRateINR":247526.6244,"date":"29-Apr-2024","totalValueINR":"6188165.61","totalValueInUsd":"74103.3","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"9478656","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726684200,"product":"VELPATASVIR SOLID DISPERSION 50 PCT W\/WPHARMACEUTICAL (ALLOPATHIC) RAW MATERIAL OF PHARMACEUTICAL GRADE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"MCB BANK LIMITED","customerCountry":"PAKISTAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"3000","totalValueFC":"74319.8","currency":"USD","unitRateINR":249123.68600000002,"date":"19-Sep-2024","totalValueINR":"6228092.15","totalValueInUsd":"74319.8","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4147734","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637346600,"product":"VELPATASVIR, BATCH NO - ZJ004@210203, CAS NO. 1377049-84-7","address":"1017\/1018, CORPORATE AVENUE,,SONAW ALA ROAD,GOREGAON EAST,","city":"MUMBAI MAHARASHTRA,MAHARASHTRA","supplier":"ALARIS PHARMACEUTICALS PTE ","supplierCountry":"CHINA","foreign_port":"NA","customer":"DELTA BIOPHARMA PVT.LTD.","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"4120","totalValueFC":"20773.9","currency":"USD","unitRateINR":"309412","date":"20-Nov-2021","totalValueINR":"1547060","totalValueInUsd":"20773.9","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"6337773","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"1017\/1018, CORPORATE AVENUE,,SONAW ALA ROAD,GOREGAON EAST,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641407400,"product":"VELPATASVIR","address":"26, MANOJ INDUSTRIAL ESTATE, G.D. AMBEKAR MARG, WADALA","city":"MUMBAI, MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS I & E CORP","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"FREDUN PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"4095","totalValueFC":"2120.5","currency":"USD","unitRateINR":"315929.3","date":"06-Jan-2022","totalValueINR":"157964.63","totalValueInUsd":"2120.5","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"6980743","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"26, MANOJ INDUSTRIAL ESTATE, G.D. AMBEKAR MARG, WADALA"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659119400,"product":"VELPATASVIR BATCH NO.:RD-VLP-202202201 MFG DATE:FEB.20, 2022EXP DATE: FEB.20, 2024(AS PER ADVANCE LIC)","address":"A-202, 2ND FLOOR, MONDEAL SQUARE BLDG,VEJALPUR:OPP:KARANAVATI CLUB,","city":"S.G. HIGH WAY,AHMEDABAD, GUJARAT.","supplier":"CHANGZHOU PHARMACEUTICAL FACTORY","supplierCountry":"CHINA","foreign_port":"NA","customer":"MEDWISE OVERSEAS PRIVATE ","customerCountry":"INDIA","quantity":"1.40","actualQuantity":"1.4","unit":"KGS","unitRateFc":"4000","totalValueFC":"5701","currency":"USD","unitRateINR":"323800","date":"30-Jul-2022","totalValueINR":"453320","totalValueInUsd":"5701","indian_port":"AHMEDABAD AIR","hs_no":"29349990","bill_no":"9799958","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-202, 2ND FLOOR, MONDEAL SQUARE BLDG,VEJALPUR:OPP:KARANAVATI CLUB,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720204200,"product":"VELPATASVIR (1377049-84-7) (INV NO.ST20240618\/ST20240619)","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ","city":"AMRITSAR,PUNJAB","supplier":"M\/S. QUANZHOU FORTUNE BIOPHARMA CO.LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"KWALITY PHARMACEUTICALS","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3300","totalValueFC":"6667.8","currency":"USD","unitRateINR":"278685","date":"06-Jul-2024","totalValueINR":"557370","totalValueInUsd":"6667.8","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"4356231","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"ADD:ROOM2603,RONG TAI\\'AN BUILDING,NO.139 JINHUAI STREET,FENGZE ROAD,FENGZE DISTRICT, QUANZHOU CITY,FUJI CHINA","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721845800,"product":"VELPATASVIR BATCH NO. : VLP-702-240401","address":"A-202, 2ND FLOOR, MONDEAL SQUARE","city":"S.G. HIGH WAY,AHMEDABAD, GUJARAT.","supplier":"CHANGZHOU PHARMACEUTICAL FACTORY","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MEDWISE OVERSEAS PRIVATE ","customerCountry":"INDIA","quantity":"5.93","actualQuantity":"5.93","unit":"KGS","unitRateFc":"2850","totalValueFC":"17094.4","currency":"USD","unitRateINR":"240967.5","date":"25-Jul-2024","totalValueINR":"1428937.28","totalValueInUsd":"17094.4","indian_port":"Ahmedabad Air","hs_no":"29349990","bill_no":"4693391","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.518 LAODONG EAST ROAD, CHANGZHOU, JIANGSU PROVINCE CHINASDNF CHINA","customerAddress":"A-202, 2ND FLOOR, MONDEAL SQUARE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"VELPATASVIR","address":"G\/6, INDL ESTATE, GORWA","city":"GUJARAT","supplier":"BEIJING MESOCHEM TECHNOLOGY CO., LT","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"CENTURION LABORATORIES","customerCountry":"INDIA","quantity":"6.50","actualQuantity":"6.5","unit":"KGS","unitRateFc":"2900","totalValueFC":"19029.7","currency":"USD","unitRateINR":"245340","date":"30-Sep-2024","totalValueINR":"1594710","totalValueInUsd":"19029.7","indian_port":"Bombay Air","hs_no":"29362100","bill_no":"5884106","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"D.FLOOR 23, BUILDING 9, LIPPO PLAZA ,ECONOMIC AND TECHNOLOGICALDEVELOPM ENT ZONE, BEIJING CHINA","customerAddress":"G\/6, INDL ESTATE, GORWA"}]
26-Jun-2021
30-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Coating Systems & Additives

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Co-Processed Excipients

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty